☰

Zheng Fu, Ph.D. - Publications

Affiliations: 
2002 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Oncology, Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhu X, Fu Z, Dutchak K, Arabzadeh A, Milette S, Steinberger J, Morin G, Monast A, Pilon V, Kong T, Adams BN, Prando Munhoz E, Hosein HJ, Fang T, Su J, et al. Co-targeting CDK4/6 and BRD4 promotes senescence and ferroptosis sensitivity in cancer. Cancer Research. PMID 38277141 DOI: 10.1158/0008-5472.CAN-23-1749  0.302
2023 Moore XTR, Gheghiani L, Fu Z. The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors. Cells. 12. PMID 37174744 DOI: 10.3390/cells12091344  0.303
2022 Li Q, Sun X, Yu K, Lv J, Miao C, Yang J, Wang S, Fu Z, Sun Y, Zhang H, Zhang ZS, Keller ET, Yao Z, Wang Q. Enterobacter ludwigii protects DSS-induced colitis through choline-mediated immune tolerance. Cell Reports. 40: 111308. PMID 36044853 DOI: 10.1016/j.celrep.2022.111308  0.422
2022 Fu Z, Jia B. Advances in the role of heat shock protein 90 in prostate cancer. Andrologia. 54: e14376. PMID 35075667 DOI: 10.1111/and.14376  0.367
2020 Gheghiani L, Shang S, Fu Z. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer. Scientific Reports. 10: 12327. PMID 32704044 DOI: 10.1038/s41598-020-69338-8  0.421
2016 Wu J, Ivanov AI, Fisher PB, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. Elife. 5. PMID 27003818 DOI: 10.7554/eLife.10734  0.423
2014 Huang Y, Zhao M, Xu H, Wang K, Fu Z, Jiang Y, Yao Z. RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis. Oncotarget. 5: 6734-45. PMID 25216515  0.319
2012 Zhang H, Wu J, Keller JM, Yeung K, Keller ET, Fu Z. Transcriptional regulation of RKIP expression by androgen in prostate cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 30: 1340-50. PMID 23095933 DOI: 10.1159/000343323  0.612
2006 Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. The Prostate. 66: 248-56. PMID 16175585 DOI: 10.1002/Pros.20319  0.626
2005 Keller ET, Fu Z, Brennan M. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. Journal of Cellular Biochemistry. 94: 273-8. PMID 15565643 DOI: 10.1002/Jcb.20169  0.638
2004 Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochemical Pharmacology. 68: 1049-53. PMID 15313400 DOI: 10.1016/J.Bcp.2004.04.024  0.594
2004 Keller ET, Fu Z, Yeung K, Brennan M. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. Cancer Letters. 207: 131-7. PMID 15151133 DOI: 10.1016/J.Canlet.2004.02.006  0.649
2004 Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. The Journal of Biological Chemistry. 279: 17515-23. PMID 14766752 DOI: 10.1074/Jbc.M313816200  0.571
2004 Fu Z, Smith P, Zhang L, Rubin M, Dunn R, Yao Z, Keller E. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis Urologic Oncology: Seminars and Original Investigations. 22: 78-79. DOI: 10.1016/j.urolonc.2003.12.006  0.597
2003 Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. Journal of the National Cancer Institute. 95: 878-89. PMID 12813171 DOI: 10.1016/J.Urolonc.2003.12.006  0.632
2002 Zhang J, Dai J, Lin DL, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 17: 1256-63. PMID 12096839 DOI: 10.1359/Jbmr.2002.17.7.1256  0.481
2002 Fu Z, Dozmorov IM, Keller ET. Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. The Prostate. 51: 10-20. PMID 11920953 DOI: 10.1002/Pros.10056  0.612
2001 Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. The Journal of Clinical Investigation. 107: 1235-44. PMID 11375413 DOI: 10.1172/Jci11685  0.576
2000 Dai J, Lin D, Zhang J, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. The Journal of Clinical Investigation. 106: 887-95. PMID 11018077 DOI: 10.1172/Jci10483  0.468
Show low-probability matches.